headshot

Ehab L. Atallah, MD

Professor

Location

  • Cancer Center - Froedtert Hospital
  • 8800 West Doyne Ave.
  • Milwaukee, WI 53226

Specialties

  • Medical Oncology
  • Hematology

Cancer Center - Froedtert Hospital

Moorland Reserve Health Center

My interest is in the treatment of patients with leukemia and other hematological malignancies. My main goal is individualized patient care because each patient has different issues, opinions and priorities. I believe this can best be achieved by good communication and actively involving patients in their care.

Overview

Diseases and Conditions

  • Acute and Chronic Myeloid Leukemia
  • Acute Lymphocytic Leukemia (ALL)
  • Chronic Lymphocytic Leukemia (CLL)
  • Leukemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Disorders

Treatments and Services

  • Virtual Visit

Patients Ages Seen

  • Adult
  • Senior

Languages

  • Arabic
  • English

Hospital Affiliations

  • Froedtert Hospital – Milwaukee

Board Certifications

  • Hematology
  • Internal Medicine

Clinic Locations

Cancer Center - Froedtert Hospital

Zablocki VA Medical Center

map of clinics' locations

Biography

Ehab Atallah, MD, is a Professor of Medicine and Section Head of hematological malignancies in the Medical College of Wisconsin Division of Hematology and Oncology, specializing in leukemia, myelodysplastic syndromes, myeloproliferative neoplasms and other bone marrow failure disorders at Froedtert Hospital. He graduated from Cairo University School of Medicine in 1994, then completed an internal medicine residency in the Cleveland Clinic Health System and a fellowship in hematology/oncology at the Karmanos Cancer Center in Detroit, Michigan, where he also served as Chief Fellow. He then went on to complete a leukemia fellowship at M.D. Anderson Cancer Center in Houston, Texas. Dr. Atallah is board certified/eligible in Internal Medicine, Medical Oncology, and Hematology. He has authored numerous publications, including journal articles, meeting abstracts, and book chapters. His current research interests are treatment of patients with chronic myelogenous leukemia, chronic lymphocytic leukemia, acute lymphocytic leukemia, acute myelogenous leukemia, myeloproliferative neoplasms and myelodysplastic syndromes. He is also the administrative director of the H Jean Khoury Cure CML Consortium (HJKC3). The HJKC3 was established in 2016 and is a collaborative effort of physicians and researchers at 21 academic medical centers committed to CML research and improving patient care and quality of life.

 

 

Education and Training

Doctor of Medicine - Kasr Al-Ainy Medical School - Cairo (1994)
Residency in Internal Medicine - Fairview General Hospital, Cleveland Clinic Health System - Cleveland, OH (2001-2003)
Fellowship in Leukemia - M. D. Anderson Cancer Center - Houston, TX (2006-2007)
Fellowship in Hematology/Oncology - Karmanos Cancer Institute, Wayne State University - Detroit, MI (2003-2006)